Target intelligence / Profile preview

Synaptonemal complex central element protein 1-like (SYCE1L)

Target
SYCE1L
Molecular classification
Other (Structural meiotic complex protein)
01

Overview

Synaptonemal complex central element protein 1-like (SYCE1L) is a protein highly similar to Synaptonemal complex central element protein 1 (SYCE1), which is a recognized component of the central element of the synaptonemal complex, a meiosis-specific protein assembly essential for the synapsis of homologous chromosomes, crossing-over, and ensuring accurate chromosome segregation during meiosis[4]. SYCE1 itself is a structural protein critical for assembling and stabilizing the central region of the synaptonemal complex; SYCE1L is presumed to have a related, possibly redundant or tissue-specific function, although it is much less studied and specific functional details are lacking. There is no current evidence that SYCE1L is a therapeutic target, nor is it involved in classical receptor, enzyme, or transporter-mediated drug interactions. It primarily acts as a structural element during meiotic prophase in germ cells, not in somatic disease or as a druggable molecule. Note: The submitted target is problematic: the entity "SYCE1L" is often minimally characterized and may be an inferred or predicted gene based on sequence similarity to SYCE1. Most characterized work focuses on SYCE1 (without the -like suffix), with little direct characterization or experimental validation for SYCE1L in the literature as of this date. If you are interested in the central element of the synaptonemal complex as a target, SYCE1 (not SYCE1L) is the canonical, well-studied form[4]. SYCE1L as a target does not currently fit common therapeutic target classes, has no known disease or drug interactions, and is not commonly referenced in disease literature. If you intend a review of SYCE1 instead, please specify, as significantly more information is available and experimentally validated for that protein.

Other names
SYCE1LMRP2Meiosis-related proteinMeiosis-related protein, MRP2Synaptonemal complex central element protein 1-likeSynaptonemal complex central element protein 1-like, meiosis-related protein, SYCE1L
02

Mechanism of action

Not established; no evidence for drug targeting

03

Biological functions

Meiotic chromosome synapsisStructural assembly of the synaptonemal complexRegulation of chromosome segregation during meiosis
04

Disease associations

Other (No clear established disease link in current literature)
05

Safety considerations

None reported
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on Synaptonemal complex central element protein 1-like (SYCE1L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptonemal complex central element protein 1-like (SYCE1L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call